Resultados de la búsqueda 211-220 de 3357 para anti-TNF drugs

  1. Neurología - Ensayos clínicos - Mayo Clinic

    Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

  2. Marihuana - Mayo Clinic

    Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed Nov. 8, 2020. Pizzorono JE, et al., eds. Cannabis (marijuana) and cannabinoids ...

  3. Oncología (médica) - Ensayos clínicos

    ... anti-PD-[L]-1 therapy. Efineptakin alfa (NT-I7) Plus Pembrolizumab for the Treatment of Recurrent Glioblastoma. Rochester, Minn. The purpose of this study is ...

  4. Medicina pulmonar - Ensayos clínicos - Mayo Clinic

    The five year follow-up period will ensure robust survival data for correlations with clinical, tumor, and treatment variables. The target of 2,500 patients is ...

  5. Neurología - Noticias de Mayo Clinic

    Mayo Clinic scientists define new type of memory loss in older adults July 17, 2024, 01:26 a.m. CDT ; Clot-busting medication helps retiree return to the open ...

  6. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    ... treatment variations, as well as the factors that ... The third aim is to measure SARS-CoV-2 anti-spike and anti ... treatment variations, as well as the ...

  7. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is assess the safety and effectiveness of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprost (TAMBE) Device in the treatment of ...

  8. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    Drugs used in chemotherapy, such as cisplatin, doxorubicin, fluorouracil, vincristine sulfate, carboplatin, etoposide, irinotecan, sorafenib, gemcitabine ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...